Chimeric antigen receptor T-cell therapy (CAR-T)

The promising CAR-T immuno-oncology approach harnesses the therapeutic power of a patient’s own immune system to fight their cancer. In an effort to improve the application of this strategy, Endocyte is leveraging its SMDC expertise in a unique way to make possible the engineering of a single universal CAR T-cell to treat multiple cancers.

Other videos...